StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.75−0.00 (-0.32%)

Close on Oct 19, 2026Market cap $1.27MP/E –Yield –

Scinai Immunotherapeutics cash

Cash and short-term investments held at the end of each period.

Scinai Immunotherapeutics's cash was $2.65M at Jun 30, 2026. For fiscal 2025 it was $1.66M, down 20.7% from the year before. The highest annual figure on record is $22.54M in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.66M-20.7%
FY2024Dec 31, 2024$2.10M-57.0%
FY2023Dec 31, 2023$4.87M-65.7%
FY2022Dec 31, 2022$14.22M-18.9%
FY2021Dec 31, 2021$17.52M+469.3%
FY2020Dec 31, 2020$3.08M-86.3%
FY2019Dec 31, 2019$22.54M+9.5%
FY2017Dec 31, 2017$20.59M+354.5%
FY2016Dec 31, 2016$4.53M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.65M-13.7%
Q4 FY2025Dec 31, 2025$1.66M-65.9%
Q2 FY2025Jun 30, 2025$989.00K-1.1%
Q4 FY2024Dec 31, 2024$2.10M-72.1%
Q2 FY2024Jun 30, 2024$3.08M-71.5%
Q4 FY2023Dec 31, 2023$4.87M-65.7%
Q3 FY2023Sep 19, 2023$1.00M-91.1%
Q2 FY2023Jun 30, 2023$7.51M-51.2%
Q1 FY2023Mar 31, 2023$10.80M-38.4%
Q4 FY2022Dec 31, 2022$14.22M+32.4%
Q2 FY2022Jun 30, 2022$11.29M+266.8%
Q1 FY2022Mar 31, 2022$15.39M-31.7%
Q4 FY2021Dec 31, 2021$17.52M-14.9%
Q3 FY2021Sep 30, 2021$10.74M+137.0%
Q4 FY2020Dec 31, 2020$3.08M–
Q4 FY2019Dec 31, 2019$22.54M–
Q4 FY2017Dec 31, 2017$20.59M–
Q4 FY2016Dec 31, 2016$4.53M–

More Scinai Immunotherapeutics figures

See a number that looks wrong?